Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,912.00
Bid: 2,913.00
Ask: 2,914.00
Change: -25.00 (-0.85%)
Spread: 1.00 (0.034%)
Open: 2,932.00
High: 2,952.00
Low: 2,905.00
Prev. Close: 2,937.00
WTB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Circ re. Sale of Costa and Notice of GM

21 Sep 2018 12:14

RNS Number : 5743B
Whitbread PLC
21 September 2018
 

Whitbread PLCPublication of Circular and Notice of General Meeting

Further to the announcement made on 31 August 2018, Whitbread PLC (the "Company" or "Whitbread") will today publish a circular (the "Circular") in relation to the proposed sale of Costa Limited to The Coca Cola Company (the "Transaction").

The Transaction is conditional on, among other things, the approval of Whitbread shareholders. Accordingly, the Circular contains a notice convening a General Meeting of the Company which is to be held at Goldman Sachs International, River Court / Brook House, 120 Fleet Street, London EC4A 2BE at 2.00 p.m. on 10 October 2018 at which an ordinary resolution will be proposed for Whitbread shareholders to approve the Transaction (the "Notice of General Meeting").

The Circular and the Notice of General Meeting have been submitted to the UK Listing Authority's National Storage Mechanism (the "NSM") and will be available for inspection on the NSM's website at www.morningstar.co.uk/uk/nsm.

The Circular and the Notice of General Meeting will also be available for viewing on Whitbread's website at www.whitbread.co.uk.

In addition to the passing of the required resolution at the General Meeting, completion of the Transaction is conditional on competition clearance from the antitrust authorities in the EU and China. The Transaction is expected to complete during the first half of 2019.

For more information please contact:

Investor queries

Matt Johnson, Whitbread PLC | matt.johnson@whitbread.com | +44 (0) 7848 146 761

Ann Hyams, Whitbread PLC | ann.hyams@whitbread.com | +44 (0) 7796 709 087

Media queries

Andrew Grant / David Allchurch / Jessica Reid, Tulchan Communications | +44 (0) 20 7353 4200

For photographs and video please visit Whitbread's media library at www.whitbread.co.uk/media.

Cautionary statement

This announcement is not intended to, and does not constitute, or form part of, any offer to sell or an invitation to purchase or subscribe for any securities or a solicitation of any vote or approval in any jurisdiction. The information contained in this announcement is not for release, publication or distribution to persons in any jurisdiction where to do so might constitute a violation of local securities laws or regulations.

Important information

Goldman Sachs International ("Goldman Sachs"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively as sponsor and financial adviser to Whitbread and for no one else in connection with the Transaction and will not be responsible to anyone other than Whitbread for providing the protections afforded to clients of Goldman Sachs or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

Morgan Stanley & Co. International plc ("Morgan Stanley"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively as sponsor, financial adviser and corporate broker to Whitbread and for no one else in connection with the Transaction and will not be responsible to anyone other than Whitbread for providing the protections afforded to clients of Morgan Stanley or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

Deutsche Bank AG is authorised under German Banking Law (competent authority: European Central Bank) and the Prudential Regulation Authority in the United Kingdom. It is subject to supervision by the European Central Bank and by BaFin, Germany's Federal Financial Supervisory Authority, and is subject to limited regulation in the United Kingdom by the Prudential Regulation Authority and Financial Conduct Authority. Deutsche Bank AG, acting through its London branch ("DB London") is acting as financial adviser and corporate broker to Whitbread and for no one else in connection with the Transaction and will not be responsible to anyone other than Whitbread for providing the protections afforded to clients of DB London nor for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

Incorporation by reference

Neither the content of Whitbread's website (or any other website) nor the content of any website accessible from hyperlinks on Whitbread's website (or any other website) is incorporated into or forms part of this announcement.

Whitbread PLC's LEI number is: 21380099VMZKRMN3EX36

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CIRFKDDDDBKDDCB
Date   Source Headline
1st Mar 20232:37 pmRNSTotal Voting Rights
28th Feb 202311:31 amRNSDirector/PDMR Shareholding
27th Feb 20233:58 pmRNSDirector/PDMR Shareholding
27th Feb 20233:58 pmRNSDirector/PDMR Shareholding
15th Feb 20232:28 pmRNSDirector/PDMR Shareholding
8th Feb 20232:51 pmRNSDirector/PDMR Shareholding
1st Feb 20232:38 pmRNSTotal Voting Rights
1st Feb 20231:17 pmRNSDirector/PDMR Shareholding
25th Jan 202310:01 amRNSBlock listing Interim Review
24th Jan 20239:02 amRNSDirectorate Change
17th Jan 202312:26 pmRNSDirector/PDMR Shareholding
16th Jan 20234:42 pmRNSDirector/PDMR Shareholding
13th Jan 20233:55 pmRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSQ3 FY23 Trading Update
9th Jan 20234:29 pmRNSDirectorate Change
20th Dec 202212:56 pmRNSDirector/PDMR Shareholding
5th Dec 202211:46 amRNSAppointment of Dominic Paul as CEO
1st Dec 20221:54 pmRNSTotal Voting Rights
15th Nov 20224:21 pmRNSDirector/PDMR Shareholding
7th Nov 20224:21 pmRNSDirector/PDMR Shareholding
27th Oct 202211:19 amRNSHolding(s) in Company
25th Oct 20227:00 amRNSWhitbread Interim Results
3rd Oct 20224:23 pmRNSHolding(s) in Company
3rd Oct 20224:22 pmRNSHolding(s) in Company
3rd Oct 202210:32 amRNSTotal Voting Rights
1st Sep 202210:36 amRNSTotal Voting Rights
24th Aug 20229:51 amRNSDirector/PDMR Shareholding
24th Aug 20228:00 amRNSMajor freehold purchase in central London
1st Aug 202211:00 amRNSTotal Voting Rights
25th Jul 20229:07 amRNSBlock listing Interim Review
21st Jul 20227:10 amRNSDirector Declaration
11th Jul 20221:39 pmRNSDirector/PDMR Shareholding
1st Jul 20223:43 pmRNSDirector/PDMR Shareholding
29th Jun 202210:15 amRNSDirectorate Change
17th Jun 20223:56 pmRNSHolding(s) in Company
15th Jun 20225:24 pmRNSResult of AGM
15th Jun 20227:00 amRNSQ1 Trading Update
10th Jun 20229:59 amRNSHolding(s) in Company
1st Jun 20224:52 pmRNSTotal Voting Rights
27th May 20224:33 pmRNSDirector/PDMR Shareholding
24th May 20224:08 pmRNSDirector/PDMR Shareholding
13th May 20221:39 pmRNSDirector/PDMR Shareholding
12th May 20224:57 pmRNSNotice of AGM
28th Apr 20224:02 pmRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSPreliminary Results Announcement
1st Apr 202212:40 pmRNSTotal Voting Rights
7th Mar 20223:57 pmRNSDirector/PDMR Shareholding
2nd Mar 20222:46 pmRNSTotal Voting Rights
1st Feb 20229:11 amRNSTotal Voting Rights
27th Jan 20227:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.